Segmentation by type distinguishes the hardware architectures that underpin the personal‑use facial and skin therapy market. LED therapy devices—including red, blue, and near‑infrared wavelengths—address a broad spectrum of indications, from collagen synthesis to bacterial reduction, and constitute approximately 30 % of unit shipments. Micro‑current devices, delivering sub‑millivolt currents to mimic cellular bio‑electrical activity, command a 25 % share, reflecting their popularity for facial toning. Ultrasonic and high‑frequency tools—which generate mechanical cavitation for deep tissue penetration—represent 20 % of the market, prized for cleansing and product absorption enhancement. Radio‑frequency (RF) units, leveraging controlled thermal energy for dermal remodeling, occupy 15 % of sales, driven by consumer interest in non‑surgical lift. Finally, Hybrid multi‑technology platforms that combine two or more modalities (e.g., LED + RF) account for the remaining 10 %, illustrating a trend toward integrated solutions that broaden therapeutic coverage while consolidating device portfolios.